Aadi Bioscience Inc (NAS:AADI)
$ 1.38 -0.02 (-1.43%) Market Cap: 33.88 Mil Enterprise Value: -52.73 Mil PE Ratio: 0 PB Ratio: 0.38 GF Score: 30/100

Aadi Bioscience Inc at Jefferies London Healthcare Conference Transcript

Nov 14, 2023 / 08:30AM GMT
Release Date Price: $4.77 (+4.61%)
Roger Song
Jefferies LLC - Analyst

All right. All right. Welcome, everyone, to day one at Jefferies Healthcare Conference in London. So our next presenting company is Aadi Bioscience. Welcome, Dave and Scott.

Scott Giacobello
Aadi Bioscience, Inc. - CFO

Good morning.

Dave Lennon
Aadi Bioscience, Inc. - President & CEO

Thank you, Roger.

Questions & Answers

Roger Song
Jefferies LLC - Analyst

Awesome. Yeah. So maybe we start from overview. If people are new to your Aadi story or know you for a while but haven't really followed for the recent updates, what is your updated elevator pitch for the investors?

Dave Lennon
Aadi Bioscience, Inc. - President & CEO

Yeah, sure. Thanks, Roger. Thanks for allowing us to attend today at Jefferies, and welcome, everyone. Thank you for coming. So we're Aadi Biosciences. I'm the new CEO, Dave Lennon. I joined in the beginning of October and have been delighted to be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot